Invesaro

Stocks Health care DRTS

NASDAQ · Health care

Alpha Tau Medical Ltd. (DRTS)

It posted a net loss of $42.6M. In fiscal 2025 capital spending exceeded operating cash flow by $32.8M. At December 31, 2025 it held $12.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 9, 2026.

Free, no password. An email when DRTS files with the SEC.

Price
$13.70
-2.91% on the day · November 10, 2026
52-week range $3.43 to $15.79
Market cap
$1.3B

Key facts about Alpha Tau Medical Ltd.

Net worth
Alpha Tau Medical Ltd. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $77.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Cash flow
In fiscal 2025 operations used $26.7M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 9, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Alpha Tau Medical Ltd. does

Alpha Tau Medical Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker DRTS.

Revenue and profit by year

Net income
FY19: -$8.4M -$8.4M FY19FY21: -$8.9M -$8.9M FY21FY21: -$27.3M -$27.3M FY21FY22: -$33.8M -$33.8M FY22FY23: -$29.2M -$29.2M FY23FY24: -$31.8M -$31.8M FY24FY25: -$42.6M -$42.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$42.3M-$42.6M-$0.53-$32.8M
2024n/a-$36M-$31.8M-$0.45-$22M
2023n/a-$35.7M-$29.2M-$0.42-$24.4M
2022n/a-$32.1M-$33.8M-$0.53-$24.8M
2021n/a-$13.8M-$27.3M-$0.67-$14.7M
2021n/a-$9.2M-$8.9M-$0.22-$11M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Alpha Tau Medical Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 29, 2026
  2. October 22, 2026
  3. October 19, 2026
  4. August 31, 2026
  5. August 10, 2026
  6. August 10, 2026
  7. July 21, 2026
  8. July 15, 2026
  9. June 25, 2026
  10. June 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 25, 2026. Insider transactions on SEC

Insider trades

What the people running Alpha Tau Medical Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $43.1K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$43.1K
last 90 days
Net sold
2,871
$43.1K
DateInsiderWhatSharesPriceValueFiling
August 21, 2026 Levy RaphiChief Financial Officer Exercised options 2,871 $2.98 $8.6K Form 4
August 21, 2026 Levy RaphiChief Financial Officer Soldpre-planned (10b5-1) 2,871 $15.00 $43.1K Form 4
August 11, 2026 Levy RaphiChief Financial Officer Exercised options 17,730 $2.98 $52.8K Form 4
August 11, 2026 Levy RaphiChief Financial Officer Soldpre-planned (10b5-1) 17,730 $14.00 $248.3K Form 4
July 6, 2026 Levy RaphiChief Financial Officer Exercised options 2,270 $2.98 $6.8K Form 4
July 6, 2026 Levy RaphiChief Financial Officer Soldpre-planned (10b5-1) 2,270 $14.00 $31.8K Form 4
July 2, 2026 Levy RaphiChief Financial Officer Exercised options 17,873 $2.98 $53.3K Form 4
July 2, 2026 Levy RaphiChief Financial Officer Soldpre-planned (10b5-1) 17,873 $13.00 $232.4K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns DRTS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Uzi Sofer13G, passive 15.8% 13,702,361 July 24, 2025

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 90,180 shares in total, about $1.2M at the last price.

HolderSharesAs of
Levy RaphiChief Financial Officer 90,180 August 21, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about DRTS

What does Alpha Tau Medical Ltd. do?

Alpha Tau Medical Ltd. is a company in the Health care sector, listed on NASDAQ as DRTS. Its shares trade on NASDAQ under the ticker DRTS.

What is Alpha Tau Medical Ltd.'s net worth?

Alpha Tau Medical Ltd. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $77.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Alpha Tau Medical Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $42.6M.

When did Alpha Tau Medical Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 9, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from October 29, 2026.

Similar companies

Compare DRTS with

Compare DRTS with any company

Follow DRTS

Get an email when Alpha Tau Medical Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when DRTS files with the SEC.

Where the numbers come from

Financial figures are the values Alpha Tau Medical Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.